Ventricular Remodeling: Clinical Trials

19 trials for Ventricular Remodeling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 7 unknown, 2 recruiting, 2 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 8, Unknown 7, Recruiting 2, Terminated 2

Follow Ventricular Remodeling: new trials by email Literature Review of Ventricular Remodeling trials Research Report on Ventricular Remodeling

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
Losartan 50 mg, Placebo - Heart Valve Diseases, Left Ventricle Remodeling
Phase 4RecruitingVitor Emer Egypto Rosa602025-07-012025-08-01
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
Henagliflozin - Myocardial Infarction, Heart Failure
Phase 4CompletedQian geng2482023-07-012025-12-02
Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA] - ST Elevation Myocardial Infarction (STEMI)
Phase 4TerminatedHenan Institute of Cardiovascular Epidemiology1192023-04-032026-05-22
Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
Colchicine, Percutaneous Coronary Intervention, Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate. - ST Elevation Myocardial Infarction, Colchicine
Phase 4UnknownRSD dr. Soebandi1482022-06-012023-04-11
Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes
Dapagliflozin, Gemigliptin - Type2 Diabetes, Remodeling, Ventricular
Phase 4UnknownWonju Severance Christian Hospital1222022-01-072023-08-01
The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
Compound Danshen Dropping Pills (CDDP), Placebo - Myocardial Infarction
Phase 4UnknownThe First Affiliated Hospital with Nanjing Medical University2682021-08-252023-04-11
Angiotensin Receptor Blockers in Aortic Stenosis
Angiotensin Receptor Blockers, Placebo - Aortic Stenosis, Aortic Valve Stenosis
Phase 4RecruitingInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval1442020-02-012024-12-20
Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
rhBNP, Control - ST Segment Elevated Myocardial Infarction
Phase 4UnknownRenJi Hospital3522019-06-192023-06-01
Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)
Ramipril - Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors
Phase 4UnknownHospital Clínico Universitario de Valladolid1942018-02-102021-09-24
Peripartum Cardiomyopathy in Nigeria Registry
Oral Sodium Selenite 200 µg/day for 3 months - Peripartum Cardiomyopathy
Phase 4CompletedAminu Kano Teaching Hospital1002017-06-122021-01-22
Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients
placebo/valsartan - First Time Dual Chamber Pacemaker Implantation
Phase 4TerminatedMedical University of Silesia882017-01-012023-04-12
Pulse Reduction On Beta-blocker and Ivabradine Therapy
Ivabradine, Placebo - Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic
Phase 4CompletedUniversity of Colorado, Denver282016-11-012023-12-20
Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction
sodium tanshinone IIA sulfonate, control - Left Ventricular Remodeling, Acute Myocardial Infarction
Phase 4UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine602015-12-012016-09-01
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
Ticagrelor, Clopidogrel - ST Elevation Myocardial Infarction
Phase 4UnknownGyeongsang National University Hospital3262014-10-012016-11-15
Danlou Tablets to Prevent Left Ventricular Remodeling
Danlou Tablets, Placebo - Left Ventricular Remodeling, Acute Myocardial Infarction
Phase 4Completedshuai Mao822012-01-012016-02-05
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
Valsartan 160mg plus HCT 25mg - Hypertension, Ventricular Remodeling
Phase 4CompletedFederico II University202008-03-012009-01-29
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
atorvastatin, placebo - Heart Failure, Congestive
Phase 4CompletedUniversity of California, Los Angeles272005-08-012020-03-20
Thrombectomy and Improvement of Left Ventricular Function in AMI
Export catheter (Medtronic) - Acute Myocardial Infarction, Ventricular Remodeling
Phase 4CompletedR&D Cardiologie502004-04-012006-02-08
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
Carvedilol, Metoprolol succinate, Metoprolol succinate + doxazosin - Idiopathic Dilated Cardiomyopathy
Phase 4CompletedUniversity of Colorado, Denver562000-09-012023-11-29

Narrower conditions

Heart Failure (3)  ·  Myocardial Infarction (3)  ·  ST Elevation Myocardial Infarction (3)  ·  Cardiomyopathy, Dilated (2)  ·  Heart Valve Diseases (2)  ·  Aortic Valve Insufficiency (1)  ·  Aortic Valve Stenosis (1)  ·  Atrial Remodeling (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Erectile Dysfunction (1)  ·  Heart Failure, Systolic (1)  ·  Hypertension (1)  ·  Peripartum Cardiomyopathy (1)

Broader conditions

Pathological Conditions, Anatomical (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Cardiovascular Diseases (13)  ·  Heart Diseases (12)  ·  Pathologic Processes (7)  ·  Vascular Diseases (7)  ·  Infarction (6)  ·  Ischemia (6)  ·  Myocardial Ischemia (6)  ·  Necrosis (6)  ·  Cardiomyopathies (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Myocardial Infarction (3)  ·  Aortic Valve Disease (2)

Interventions

Valsartan (2)  ·  Angiotensin Receptor Antagonists (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Carvedilol (1)  ·  Clopidogrel (1)  ·  Colchicine (1)  ·  Doxazosin (1)  ·  Hematocrit (1)  ·  Ivabradine (1)  ·  LC15-0444 (1)  ·  Losartan (1)  ·  Metoprolol (1)  ·  Nitrates (1)  ·  Percutaneous Coronary Intervention (1)

Sponsors

University of Colorado, Denver (2)  ·  Aminu Kano Teaching Hospital (1)  ·  Federico II University (1)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (1)  ·  Gyeongsang National University Hospital (1)  ·  Henan Institute of Cardiovascular Epidemiology (1)  ·  Hospital Clínico Universitario de Valladolid (1)  ·  Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (1)  ·  Medical University of Silesia (1)  ·  Qian geng (1)  ·  R&D Cardiologie (1)  ·  RSD dr. Soebandi (1)  ·  RenJi Hospital (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  University of California, Los Angeles (1)

Countries

China (6)  ·  United States (3)  ·  South Korea (2)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Nigeria (1)  ·  Poland (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Michael R Bristow, MD PhD (2)  ·  B. Rensing, MD, PhD (1)  ·  Ewa Nowalany-Kozielska, MD PhD Associate Professor (1)  ·  Jun Pu, MD,PhD (1)  ·  Kamilu M Karaye, PhD (1)  ·  Marie-Annick Clavel, PhD (1)  ·  Nan Bai, MD (1)  ·  Serafino Fazio, MD (1)  ·  Tamara B Horwich, MD (1)  ·  Vitor E. E. Rosa, MD, PhD (1)  ·  Yongwhi Park, MD., PhD. (1)  ·  Young-Hoon Jeong, MD.,PhD. (1)

Results publications

PMID 22041323, PMID 25637602, PMID 25858003, PMID 26482376, PMID 27056772, PMID 27825334, PMID 28132924, PMID 28138556, PMID 29142025, PMID 29311992, PMID 29440218, PMID 29932506, PMID 31074220, PMID 31370954, PMID 32470515, PMID 33032710, PMID 33087055, PMID 33397290, PMID 37656413, PMID 37732786, PMID 39291483, PMID 40052260, PMID 41730521

NIH funding

2023 (1), K23HL085097 (1), R01HL048013 (1)